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SUMMARY
The cellular mechanisms that regulate the maintenance of adult tissue stem cells are still largely
unknown. We show here that the p53 family member, TAp63, is essential for maintenance of
epidermal and dermal precursors and that, in its absence, these precursors senesce and skin ages
prematurely. Specifically, we have developed a TAp63 conditional knockout mouse and used it to
ablate TAp63 in the germline (TAp63−/−) or in K14-expressing cells in the basal layer of the
epidermis (TAp63fl/fl;K14cre+). TAp63−/− mice age prematurely and develop blisters, skin
ulcerations, senescence of hair follicle-associated dermal and epidermal cells, and decreased hair
morphogenesis. These phenotypes are likely due to loss of TAp63 in dermal and epidermal
precursors since both cell types show defective proliferation, early senescence, and genomic
instability. These data indicate that TAp63 serves to maintain adult skin stem cells by regulating
cellular senescence and genomic stability, thereby preventing premature tissue aging.
INTRODUCTION
While the cellular mechanisms that regulate mammalian aging are still largely undefined,
recent studies have suggested that aging can occur as a consequence of the functional
depletion of somatic stem cells required for maintenance of adult tissues (Sharpless and
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DePinho, 2007). Also, regenerative failure of tissues and premature aging arise in mice
lacking genes critical for genomic stability and maintenance (Hasty et al., 2003). In this
regard, the tumor suppressor p53, and its related family members, p63 and p73, have all
been linked to premature aging (Maier et al., 2004). Mice expressing a truncated mutant p53
exhibit phenotypes associated with premature aging (Tyner et al., 2002), by a mechanism
that is still under debate. Mice heterozygous for p63 show premature aging (Flores et al.,
2005; Keyes et al., 2005). However, in spite of the fact that p53 regulates cellular
senescence and genomic stability and the importance of these cellular functions to ensure
adult stem cell longevity, the relationship between the two is still largely an open question.
p63 is critical for skin, limb, and nervous system development (Celli et al., 1999; Jacobs et
al., 2005; Mills et al., 1999; Yang et al., 1999). Multiple roles have been identified for p63
in the proliferation, differentiation, and maintenance of epidermal cells (Koster et al., 2007;
Senoo et al., 2007). However, the analysis of p63 function has been complicated by the
presence of multiple isoforms of p63 with various expression patterns in multiple tissues
(Flores, 2007). The full-length TA isoforms contain a transactivation domain and
structurally resemble p53, while the ΔN isoforms lack this domain and can act as dominant-
negative family members. The existence of these isoforms has complicated the interpretation
of the role of p63 in multiple processes including its role as a tumor suppressor (Flores,
2007; Flores et al., 2005). With regard to the epidermis, the functions of the TA and ΔN
isoforms of p63 have been examined by overexpression or knock down in early
differentiating keratinocytes (Candi et al., 2006; Koster et al., 2007). These studies, together
with the high relative expression of ΔNp63 in the epidermis suggest that the ΔNp63 and not
TAp63 isoforms are critical for epidermal development and maintenance. More recently, a
TAp63−/− mouse was created showing that this isoform is critical for protection of the
female germline (Suh et al., 2006). However, these approaches have not demonstrated a
specific role for TAp63 in the epidermis, nor have they addressed a potential role for p63 in
the mesenchymal compartment of the skin or other epithelial tissues that are affected in the
p63−/− mice.
To understand the role of TAp63 in skin development, we generated a conditional knock out
allele of TAp63 in the mouse, and used transgenic mice expressing the cre recombinase in
the germline (Zp3-cre and protamine-cre) (Lewandoski et al., 1997; O'Gorman et al., 1997)
or in the epidermis (K14cre) (Jonkers et al., 2001) to target genetic ablation of TAp63. We
found that mice generated with germline deletion of TAp63 (TAp63−/−) develop blisters,
ulcerated wounds, decreased wound healing, and accelerated aging. Surprisingly, our data
indicate that these phenotypes were due to the loss of TAp63 in a dermal precursor
population that resides within a hair follicle niche (Fernandes et al., 2004; Toma et al., 2001;
J. Biernaskie, L. Pevny, and F.D. Miller, unpublished observations). The loss of TAp63 in
these dermal precursors (termed SKPs for skin-derived precursors) led to hyperproliferation,
senescence, and genomic instability in culture, and premature senescence and reduced hair
follicle morphogenesis in vivo. In addition to these dermal deficits, cultured TAp63−/−
epidermal cells displayed decreased colony formation, increased senescence, and genomic
instability. Together, these findings indicate that TAp63 serves to maintain adult tissue stem
cells thereby preventing premature aging, and to provide direct evidence that TAp63 has an
important role in regulating cellular senescence and genomic stability.
EXPERIMENTAL PROCEDURES
Generation of TAp63 conditional knockout mice
The cre-loxP strategy was used to generate the TAp63 conditional knockout allele
(TAp63fl). Genomic p63 DNA from intron 1 to 3 was amplified from BAC clone DNA
(BAC RP23-186N8, Children’s Hospital Oakland Research Institute). LoxP sites flanking
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exon 2 and neomycin (neo) gene flanked by frt sites inserted in intron 2 were cloned into
pL253 (Liu et al., 2003). ES cells were analyzed by Southern blot analysis. Chimeras
resulting from ES cell clones injected into C57BL/6 blastocysts were mated with C57BL/6
albino females, and genotyped as described below. Mice with germline transmission of the
targeted allele (conditional, floxed allele) were crossed with Zp3-Cre (C57BL/6)
(Lewandoski et al., 1997) or Protamine-Cre (C57BL/6 × 129S6) (O'Gorman et al., 1997)
transgenic mice. All procedures were approved by the IACUC at U.T. M.D. Anderson
Cancer Center and by the Hospital for Sick Children Care Committee and were within the
guidelines of the Canadian Council of Animal Care.
Blister Analysis
Thirty wild-type and TAp63−/− mice housed individually were observed throughout life for
macroscopic phenotypic changes. Mice were sacrificed at 1, 2, and 4 months for blister
characterization. Immunocytochemistry was performed using anti-collagen IV (1:80,
Abcam) and anti-K14 (1:2000, Dennis Roop) followed by Texas Red-conjugated goat anti-
rabbit and FITC conjugated goat anti-guinea pig secondary antibodies (1:1000, Jackson
ImmunoResearch).
Wound healing assay
Mice were anesthetized and two 5 mm diameter full thickness punch wounds were made on
each side of the dorsum using Acu-Punch (Acuderm Inc.). Mice were housed individually
and wounds were measured at days 0, 1, 2, 4, and 6. At day 6, mice were euthanized and one
half of the epithelium was fixed in 10% formalin and the other frozen in OCT medium
(Tissue Tek). 1.2 mg/kg buprenorphine was injected subcutaneously for pain management.
Primary keratinocyte isolation and colony formation
Cells were isolated from skin of P1 mice or embryos at day 18.5 (E18.5) by treatment with
DispaseII (Roche). The separated epidermis was minced and incubated in 0.25% trypsin/
EDTA (GIBCO) for 20 minutes. Cells were plated on collagen-coated flasks (50 µg/ml)
collagen type I (BD Bioscience) in defined K-SFM medium (GIBCO). 5×103 cells were
plated on 60mm dishes containing mitomycin c (Roche)-treated J2 3T3 feeder cells in F
media as described (Barrandon and Green, 1987). Colonies cultured for 8, 12, or 20 days
were fixed in 10% formalin, and stained with 2% rhodamine B (Sigma) or with the
following antibodies: anti-cytokeratin 5 (Abcam) (1:1000), anti-cytokeratin 10 (Chemicon)
(1:1000), and anti-gamma-H2AX-FITC (Upstate Biotechnology)(1:100). Secondary
antibodies used were FITC- or Texas Red-conjugated (Jackson ImmunoResearch)(1:500).
Some dishes were treated with 10 mM BrdU for 15 hours and immunostained for BrdU
(Becton Dickinson). Apoptotic cells were detected with the FragEL kit (Calbiochem).
SKP Isolation and culture
Dorsal and whisker pad skin were removed from E18 embryos, young (1 month), or aged
(12 months) mice as described previously (Biernaskie et al., 2006). To transfect SKPs,
25,000 cells were plated on coated (1% Poly-D Lysine and 1% Laminin) chamber slides and
transfected with pCMV-p57Kip2 or pCMV-EGFP expression vectors using the Fugene
reagent. 48hrs after transfection, cells were fixed in 4% paraformaldehyde and analyzed for
expression of p57Kip2 and Ki67 by immunocytochemistry
Sox2-EGFP sorted cells
Dorsal skin samples from adult (n=3) Sox2-EGFP mice (Ellis et al., 2004) were
enzymatically digested. Viable cells were gated. Sox2-EGFP-negative, Sox2-EGFP-positive,
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or total live cells were collected by flow cytometry using a MoFlo (Dako) cell sorter and
analyzed by RT-PCR.
Cytogenetics
Primary keratinocytes treated with colcemid (0.02 mg/ml) and fixed in 75% methanol / 25%
acetic acid were dropped onto slides and stained with 5.0% Giemsa in PBS (pH 6.8). Images
were processed with MetaMorph Premier (Molecular Devices) using a Nikon Eclipse E400
microscope.
Statistics
All data are represented as mean ± SEM. Data were analyzed using one-way ANOVA test
or student’s t-test for comparison between two groups. A p-value of 0.05 was considered
significant. All experiments were done at least in triplicate.
RESULTS
Generation of a TAp63 conditional knockout mouse
We generated a TAp63 conditional knock out mouse (TAp63fl) using the cre-loxP system
(Fig. 1) allowing for tissue specific deletion of the TAp63 isoforms and retention of the
ΔNp63 isoforms. LoxP sites were inserted in to the p63 gene flanking exon 2, which
contains the translational start site of the TAp63 isoforms, to generate a floxed allele
(TAp63fl) (Fig. 1A). Properly targeted embryonic stem (ES) cells were injected into donor
blastocysts and subsequently into pseudopregnant females. Resulting male chimeras were
intercrossed with albino C57/B6 females for germline transmission scored by PCR and
Southern blot analysis (Fig. 1B & C).
Generation of a TAp63−/− mouse
To further understand the role of TAp63 in skin development, a TAp63−/− mouse was
generated by intercrossing the TAp63fl mouse (TAp63fl/fl) with germline-specific cre
transgenic mice (Zp3-cre and protamine-cre)(Lewandoski et al., 1997; O'Gorman et al.,
1997). We detected embryonic lethality (35%) on an enriched C57B/6 background (~95%)
but not upon subsequent backcrossing to the 129S6 strain. Quantitative RT-PCR performed
on keratinocytes isolated from TAp63−/− newborn mice confirmed absence of TAp63
mRNA (p<0.0001) (Fig. 1D) or protein expression (Fig. 1F) with maintenance of wild-type
levels of ΔNp63 mRNA (Fig. 1E) and protein (Fig. 1G) throughout embryonic
development.
TAp63−/− mice develop blisters, ulcerated wounds, and accelerated signs of aging
The TAp63−/− mice that survived to birth exhibited small skin blisters in early adulthood
and signs of accelerated aging at later stages, including ulcerated wounds, and premature
death (Fig. 1H). By one month of age, 33% of TAp63−/− mice developed blisters that
ultimately led to ulcerated wounds on their dorsal and ventral sides (Figs. 1H–K). Keratin 14
and collagen IV immunostaining revealed a subepidermal split between the basement
membrane and the dermis with accumulation of entrapped serum (Figs. 1I & K). While the
blisters themselves are not likely a sign of premature aging, the wounds that result from
these ruptured blisters progress to severe skin ulcerations that fail to heal with aging (Fig.
1H). The other 66% of the cohort developed blisters and ulcerations by 2 to 4 months. In
addition, the TAp63−/− mice exhibited signs of premature aging. By X-ray analysis, we
found that twenty-five percent of TAp63−/− mice (n=28) developed kyphosis by 8 months
and 86% developed this condition by 10 months compared to 14% in the wild-type mice at
10 months (n=29) (Fig. 1L). Defects in other epithelial tissues were also noted within the
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kidney, stomach, esophagus, and bladder leading to the development of multiple cysts in
these tissues. Finally, the median lifespan of the TAp63−/− mice was only 333 days
compared to 712 days for wild-type mice (n=28) (p<0.001) (Fig. 1M).
One possible explanation for these premature aging phenotypes is that TAp63 is essential for
maintenance of the adult precursor populations that maintain tissues. To address this
possibility, we determined whether p63 was expressed in the dermis in addition to its
reported expression in epidermal precursors and keratinocytes (Senoo et al., 2007).
Immunocytochemical analysis of adult skin for p63 and antibodies specific for epidermal
versus dermal cells demonstrated that p63 was expressed in epidermal cells of the hair
follicle, where it was localized to the nucleus (Fig. 2A). However, it was also expressed in
the fibronectin-positive dermal sheath (DS) cells of the hair follicle and in a subpopulation
of NCAM-positive dermal papilla cells, where it was localized to the cytoplasm (Fig. 2A),
as has been reported in other cell types (Kurita et al., 2005). To confirm this result, we took
advantage of the finding that hair follicle DP and DS cells express a Sox2:EGFP reporter,
and are the only cells to do so within adult backskin from the mouse (J. Biernaskie, L.
Pevny, and F.D. Miller, unpublished observations). Following isolation of Sox2:EGFP-
positive cells by cell sorting from Sox2:EGFP mice (Ellis et al., 2004), RT-PCR analysis
demonstrated that TAp63 was expressed in these cells (Fig. 2B), and therefore, in follicle
DP and DS cells. TAp63 was also expressed in the negative fraction, presumably in the
Sox2-negative epidermal cells. Since the follicle dermal sheath and the related dermal
papilla are niches for skin-derived precursors (SKPs), an adult dermal precursor population
implicated in hair follicle morphogenesis and dermal maintenance (Fernandes et al., 2004; J.
Biernaskie, L. Pevny, and F.D. Miller, unpublished observations), then this suggests that p63
is expressed in precursor cell populations in both the dermis and epidermis.
To determine whether TAp63 is essential for maintenance of these precursor populations,
we stained sections of young adult skin (1 month) for senescence-associated β-galactosidase
(SA-β-gal), a marker for cellular senescence. SA-β-gal staining was undetectable in sections
of young wild-type skin (Fig. 2C), but was localized to the bulge region, the dermal sheath,
and papilla of hair follicles in TAp63−/− mice (Suppl. Fig. 1 & Fig. 2C). Quantification
demonstrated a 15-fold increase in total SA-β-gal-positive hair follicles (Suppl. Fig. 1B) and
a 2-fold increase in hair follicles with SA-β-gal-positive dermal papillae in young TAp63−/−
skin (Fig. 2D). Interestingly, similar SA-β-gal staining in follicle dermal cells was observed
in aged wild-type skin at 12 months (Fig. 2D), suggesting that in the absence of TAp63,
precursor cells senesce prematurely.
To investigate whether this premature senescence has functional consequences, we
quantified hair follicles in backskin from TAp63−/− and wild-type mice at 1 to 12 months.
Young mice of both genotypes and wild-type skin at all ages had a similar density of hair
follicles (7–8 hair follicles/mm) that were uniformly distributed over the entirety of the
backskin (Fig. 2E & F). In contrast, aged (6–12 month) TAp63−/− skin exhibited many
areas where there were no hair follicles at all (Fig. 2E) interspersed with areas where the hair
follicle density was similar to that of wild-type mice (Fig. 2E). We measured the percentage
of skin lacking hair follicles across gaps of greater than 400 µm. This analysis demonstrated
that, at 1 month, hair was evenly distributed along the backskin of both wild-type and
TAp63−/− mice, with virtually no gaps (Fig. 2E–G). By 6–12 months, occasional hairless
patches were noted in the wild-type mice, occurring as part of the normal aging process. In
contrast, 30–40% of the TAp63−/− backskin was hairless by 6–12 months (Fig. 3G).
To determine whether this age-dependent hair follicle loss was due to immune-mediated
destruction of hair follicles, skin from 27 TAp63−/− mice and 12 wild-type mice aged 1 to
12 months were examined. No perifollicular lymphocytic infiltrates composed of T-cells
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were apparent in these samples. Additionally, in autoimmune diseases where hair follicles
are destroyed, affected areas show perifollicular scarring (fibrosis) as well as fibrous tracts
that mark areas where intact follicles once stood (Ackerman, 1997). None of the samples
examined showed such evidence. To further confirm that this hair follicle loss was not due
to immune-mediated destruction, we immunostained sections for the T-cell marker (CD3)
and for the macrophage marker (Iba-1). Immunostaining for the T cell marker, CD3, was
performed on 11 TAp63−/− and 3 WT mice at early time points (less than 6 months of age)
(Suppl. Fig. 2) and demonstrated no significant differences in lymphocytic infiltrates or
evidence of active follicular injury. Similar results were obtained with immunostaining for
the macrophage marker Iba-1 (Suppl. Fig. 3), indicating that the blistering and hair follicle
loss seen in TAp63−/− mice was not due to an aberrant immune attack. These data, together
with the skin ulceration phenotype observed in TAp63−/− mice, indicate that TAp63 is
essential for maintenance of both epidermal and dermal stem cell populations, and that in its
absence, there are patches of skin where hair follicles are absent and large skin ulcers form,
due to premature aging/senescence of these precursors.
TAp63 is essential for wound healing
Adult tissue stem cells are essential not only for tissue maintenance, but also for appropriate
wound-healing responses. To assess whether this skin ulceration phenotype was due to
aberrant wound-healing, we performed a wound-healing assay using wild-type and TAp63−/
− mice at one month (Fig. 3A & B). Five millimeter punch wounds were made on the dorsal
side of wild-type and TAp63−/− mice, and six days later, wound sizes were measured.
Wounds in TAp63−/− mice had not healed and were almost twice as larger as those in wild-
type mice (Fig. 3A–C). Consistent with these findings, BrdU incorporation in the epidermis
of TAp63−/− mice was less than half of that in wild-type mice (Fig. 3D–F). Similarly, levels
of BrdU incorporation were low in the dermis of wounded TAp63−/− mice (Fig. 3K). Thus,
TAp63 is necessary to ensure appropriate dermal and epidermal wound-healing responses.
Deletion of TAp63 in K14-positive cells is not sufficient to recapitulate the TAp63−/−
phenotypes
To determine whether these skin phenotypes were due to the loss of TAp63 in the epidermal
compartment, we first asked whether TAp63 was expressed in epidermal cells in vivo.
Consistent with previous studies (Koster et al., 2004), TAp63 was not detected in the intact
epidermis of wild-type mice. However, when skin was wounded and double-labeled for
TAp63 and keratin 5, a marker for the basal layer of the epidermis, scattered epidermal cells
within the wound site of wild-type mice expressed TAp63 (Fig. 3G–J) indicating it
induction in response to stress. Indeed, wild-type passage 2 keratinocytes exhibited an
induction of TAp63 while freshly isolated keratinocytes (passage 0) did not (Fig. 3M). To
determine whether epidermal TAp63 is essential for appropriate wound-healing, we
generated mice with a selective deletion of TAp63 in the epidermal compartment using
keratin 14 (K14) cre transgenic mouse (Jonkers et al., 2001), which expresses the cre-
recombinase in the basal layer of the epidermis. Consequently, dermal, but not epidermal,
cells in these mice are wild-type. Quantitative RT-PCR analysis of epidermal cells derived
from the intact epidermis of TAp63fl/fl;K14cre mice at E18.5 showed that TAp63 mRNA
was not detectable, similar to what was seen with epidermal cells derived from TAp63−/−
mice (Fig. 3L). To confirm that TAp63 was deleted in epidermal cells from TAp63fl/
fl;K14cre mice, we derived keratinocytes from TAp63fl/fl;K14cre, passaged them in culture,
and then performed Western blots (Fig. 3N). This analysis demonstrated that TAp63 was
induced and detectable in cultured wild-type keratinocytes, as was p53 (Fig. 3M), but that no
TAp63 was observed in passaged keratinocytes cultured from TAp63fl/fl;K14cre mice (Fig.
3N). These results indicate that most epidermal cells from TAp63fl/fl;K14cre mice extracted
at E18.5 do not express TAp63, although it is possible that cre-mediated excision of the
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floxed allele is incomplete in epidermal cells, particularly given the low endogenous levels
of TAp63 expression.
Interestingly, TAp63fl/fl;K14cre mice did not display any overt skin phenotypes under
normal conditions suggesting that loss of TAp63 in K14-expressing epidermal cells alone
was insufficient to cause the skin ulcerations seen in TAp63−/− mice. To further address this
issue, we performed punch biopsies on the TAp63fl/fl;K14cre mice. Analysis of wound-
healing revealed that TAp63fl/fl;K14cre and wild-type mice healed their wounds at similar
rates (Fig. 3C). Likewise, the levels of BrdU incorporation in the epidermis and dermis of
TAp63fl/fl;K14cre mice were similar to those in wild-type mice (Fig. 3F & K). Together,
these data suggest that loss of TAp63 in most keratinocytes is not sufficient to recapitulate
the skin ulceration or wound-healing deficit observed in TAp63−/− mice.
TAp63 is essential for colony formation from epidermal precursors
Since p63 has been implicated in the proliferation of epidermal stem cells (Senoo et al.,
2007), we asked whether this phenotype was due to loss of TAp63. We isolated and cultured
epidermal cells from newborn wild-type and TAp63−/− mice (Fig. 4A) (Barrandon and
Green, 1987), analyzed colonies at 8, 12, and 20 days to observe their proliferative and self
renewal capacities. Wild-type cells generated colonies containing keratin 5 (K5) positive
immature keratinocytes, the majority of which contained up to 50% BrdU-positive
proliferating cells at 8 and 20 days (Fig. 4A–D). In contrast, TAp63−/− epidermal cells
generated small, irregular-shaped colonies of K5-positive cells, the majority of which
contained no proliferating cells at 8 or 20 days (Fig. 4A–D). In spite of this perturbation in
colony formation, cells within these TAp63−/− colonies differentiated and expressed keratin
10, a marker of the spinous layer of the epidermis, following treatment with high calcium
(Fig. 4E). This deficit in colony formation is similar to that seen with knockdown of all p63
isoforms in epidermal precursors (Senoo et al., 2007), and indicates that TAp63 is required
for epidermal precursor proliferation and/or the appropriate genesis of proliferation-
competent keratinocytes.
We also performed similar experiments with epidermal cells isolated from TAp63fl/
fl;K14cre mice (Fig. 4A–D). These cells formed colonies and proliferated like wild-type
epidermal cells. These data are consistent with the lack of skin phenotypes in the TAp63fl/
fl;K14cre mice.
Since the p53 family members interact extensively, we asked whether this colony formation
phenotype could be rescued by coincident loss of p53. Thus, colony formation assays were
performed with epidermal cells isolated from TAp63−/−;p53−/− mice (Fig. 4A). Eight days
after culture, p53 deletion partially rescued the TAp63−/− phenotype; wild-type and
TAp63−/−;p53−/− epidermal cells generated similar numbers of colonies with 50% or fewer
proliferating cells, but only 18% of TAp63−/−;p53−/− colonies (p=0.038) had >50% BrdU
positive cells compared to 28% of wild-type and 6% of TAp63−/− colonies (p=0.020) (Fig.
4C). This rescue was not, however, apparent at 20 days, when TAp63−/−;p53−/− colonies
were similar to TAp63−/− colonies, and statistically different from wild-type colonies (Fig.
4D). Thus, coincident loss of p53 partially rescued the TAp63−/− colony formation
phenotype at short but not long culture time points (Fig. 4A, C, & D).
TAp63 regulates self-renewal of dermal precursor cells
These data suggest that the skin phenotypes in TAp63−/− mice require the loss of TAp63 in
dermal cells. We therefore asked whether TAp63 regulated SKPs, dermal precursors within
a niche in the hair follicle where p63 is expressed (Fig. 2A & B). We isolated wild-type
SKPs and characterized the repertoire of p53 family members expressed by RT-PCR.
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Consistent with the expression of p63 in hair follicle Sox2:EGFP-positive dermal cells in
vivo (Fig. 2A & B), SKPs expressed detectable TAp63 mRNA (Fig. 5A). but not ΔNp63 or
p73. p53 levels were similar in SKPs that were isolated from the dermis of p63−/− and wild-
type embryos (Fig. 5A & B). Immunostaining for p63 confirmed that SKPs isolated from
neonatal dermis or hair follicles expressed detectable p63 protein (Fig. 5C). Thus, of the p53
family members, SKPs express only TAp63 and p53, and expression of p53 family members
is not dysregulated by the absence of p63.
To determine whether TAp63 is necessary for maintenance of SKPs, we isolated them from
1 month TAp63−/− and wild-type skin. Immunocytochemical analysis of SKP spheres for
fibronectin, nestin, vimentin, and versican, all markers that have been defined for SKPs
(Biernaskie et al., 2006; Fernandes et al., 2004; Toma et al., 2001) demonstrated that there
were no overt differences in expression of these SKP markers with the loss of TAp63 (Fig.
5D). However, immunostaining for the proliferation marker Ki67 demonstrated that
TAp63−/− SKPs isolated from young mice proliferated approximately 4–5-fold more than
wild-type counterparts (Fig. 5F). Similar results were obtained when SKPs were isolated
from the rudimentary dermis of E18 p63−/− embryos (Fig. 5E, F). To determine if this
increased proliferation reflected increased self-renewal, SKPs were dissociated to single
cells, plated at low density in medium containing methylcellulose, and the percentage of
cells that initiated a new sphere was determined. As seen in the proliferation assay, SKPs
cultured from postnatal TAp63−/− and E18 p63−/− mice self-renewed 3–4 times more
robustly than did wild-type SKPs (Fig. 5G). In spite of this hyperproliferation, TAp63−/−
and wild-type SKPs were still able to differentiate into both neural and mesodermal cell
types under previously defined conditions (Suppl. Fig. 4A) and when transplanted into the
neural crest migratory stream of embryonic chicks in ovo at HH stage 18, both populations
of SKPs migrated into neural crest targets (Suppl. Fig. 4B) (Fernandes et al., 2004). Thus,
TAp63 regulates SKP proliferation and self-renewal, but does not overtly affect their
phenotype, differentiation, or migratory capacity.
These data suggest that TAp63 normally functions to dampen the self-renewal rate of SKPs,
potentially as a mechanism for ensuring that they last for the lifetime of the animal. One p63
target that decreases cellular proliferation is the cyclin-dependent kinase inhibitor p57Kip2
(Beretta et al., 2005). RT-PCR analysis demonstrated that p57Kip2 mRNA levels were
reduced in TAp63−/− and p63−/− SKPs (Fig. 5H). Immunocytochemistry confirmed this
result, and demonstrated that while p57Kip2 was robustly expressed in 50% of wild-type
SKPs, it was only detectably expressed in 18% of TAp63−/− SKPs (Fig. 5I,J). In contrast,
RT-PCR for two other cell cycle regulators, p27Kip1 and p21Cip1 demonstrated unchanged
expression in the absence of p63 (Suppl. Fig. 4C). Chromatin immunoprecipitation for p63
identified a previously-defined binding site in the p57Kip2 promoter (Fig. 5K). We therefore
asked if the hyperproliferation phenotype in TAp63−/− SKPs could be rescued by p57Kip2.
Following transfection of TAp63−/− SKPs with either empty vector or p57Kip2, 20% of cells
transfected with p57Kip2 expressed detectable levels of this protein, and none of these
transfected cells coexpressed Ki67 (Fig. 5L). In contrast, approximately 45% of TAp63−/−
cells transfected with the empty vector were dividing, as monitored by Ki67, and none of
them expressed p57Kip2 (Fig. 5L). Thus, p57Kip2 completely rescued the hyperproliferation,
indicating that TAp63 regulates SKPs self-renewal at least in part by regulating p57Kip2.
Loss of TAp63 causes dermal precursors to senesce
To investigate whether TAp63−/− precursors senesce, SKPs were generated from 1 month
TAp63−/− and wild-type skin and analyzed for expression of SA-β-gal and p16Ink4a, a
second marker for senescence that is associated with human aging (Sharpless and DePinho,
2007). SA-β-gal staining demonstrated that a very large proportion of the cells in TAp63−/−
SKP spheres were SA-β-gal-positive (Fig. 6A). Similarly, immunostaining for p16Ink4a
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revealed that over 50% of the cells in SKP spheres were p16Ink4a-positive versus less than
10% of the wild-type SKPs (Fig. 6B & C). Interestingly, analysis of SKPs generated from
aged wild-type skin demonstrated that 50–60% of the SKPs were also p16Ink4a-positive (Fig.
6B), supporting the notion that SKPs normally senesce as animals age, and that loss of
TAp63 causes premature aging.
Since TAp63−/− SKPs show both hyperproliferation and increased senescence, we
immunostained spheres for both Ki67 and p16Ink4a. This analysis demonstrated that these
two proteins were expressed in different populations of cells (Fig. 6B), consistent with the
idea that as SKPs senesce, they exit the cell cycle. Interestingly, however, approximately 5%
of TAp63−/− SKPs expressed both Ki67 and p16Ink4a, and in these cells, their subcellular
distribution within the nucleus was mutually exclusive (Fig. 6D), indicating that these cells
represent a transition state between hyperproliferation and senescence. These data are
consistent with the interpretation that TAp63 serves to maintain SKPs in a largely quiescent
state, and that in its absence, SKPs hyperproliferate and ultimately senesce, thereby causing
premature dermal and follicle aging.
To ask whether TAp63 is a more general regulator of cellular senescence, we examined
cultured epidermal cells for SA-β-gal. TAp63−/− cells had a dramatic increase in SA-β-gal
relative to wild-type cells (Fig. 6E). To determine whether this cellular senescence required
p53, we intercrossed the p53−/− (Jacks et al., 1994) and TAp63−/− mice. Analysis of
TAp63−/−;p53−/− cells revealed that, somewhat surprisingly, the number of SA-β-gal-
positive cells was further increased by the coincident loss of p53 (Fig. 6E). In contrast,
apoptosis, which was increased in the absence of TAp63, was rescued by coincident deletion
of p53; 0% of cultured TAp63−/−;p53−/− cells underwent apoptosis compared to 18% of
TAp63−/− and 6% of wild-type cells (Fig. 6F). Consequently, the increase of senescence in
the TAp63−/−;p53−/− cells may be due to the coincident decrease in apoptosis. Taken
together, these data suggest that TAp63 may be a general regulator of cellular senescence,
and indicate that the senescence in these cells is p53-independent.
Loss of TAp63 results in DNA damage and genomic instability
One known trigger for cellular senescence is DNA damage. In light of the wound-healing
deficits and cellular senescence seen in TAp63−/− mice, we asked whether TAp63−/− skin
cells might have accumulated DNA damage. Immunostaining for histone γH2AX, which is
induced during DNA damage, on SKPs and epidermal cells from wild-type and TAp63−/−
mice revealed that 70–80% of 1 month-old TAp63−/− SKPs expressed this DNA damage
marker (Fig. 7A & B), whereas none of the age-matched controls did. Likewise, TAp63−/−
epidermal cells had a marked increase in γH2AX nuclear foci. One hundred percent of
TAp63−/− cells were γH2AX positive compared to less than 5% of wild-type cells (Fig.
7D). To confirm the presence of genomic instability in vivo, we immunostained young and
aged skin for γH2AX. Young wild-type skin showed virtually no γH2AX-positive cells, but
aged skin showed a small population of positive cells in the dermal sheath of hair follicles
(Fig. 7C). In contrast, in 1 month-old TAp63−/− skin, γH2AX-positive cells were
consistently observed in the dermal sheath (Fig. 7C).
Because of the strikingly high levels of DNA damage, we assayed for chromosomal
instability. More than 100 metaphase spreads from primary wild-type and TAp63−/−
epidermal cells were scored for chromosomal aberrations. TAp63−/− cells had a large
number of cytogenetic aberrations including chromosomal fusions, fragments, breaks,
biarmed chromosomes, ring chromosomes, dicentric chromosomes, and aneuploidy (Fig.
7E), suggesting that TAp63 is a critical for maintenance of genomic stability.
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Here, we show that TAp63 plays an instrumental role in the maintenance and renewal of
dermal and epidermal precursors, and when this function is perturbed, it causes premature
aging of both the precursors themselves and the tissues that they maintain. We demonstrated
this by generating a conditional knockout allele of TAp63, preserving the ΔNp63 isoforms,
and intercrossing it with germline or epidermal specific cre transgenic mice. Mice with a
germline deletion of TAp63 developed blisters, ulcerated wounds, display decreased wound
healing, and an accelerated aging phenotype. Surprisingly, these phenotypes were at least
partially due to the loss of TAp63 in SKPs, dermal precursors that reside within a hair
follicle niche. Loss of TAp63 in SKPs led to hyperproliferation, senescence, and genomic
instability in culture, and premature senescence and reduced hair follicle morphogenesis in
vivo. In addition to these dermal deficits, cultured TAp63−/− epidermal precursors
displayed decreased colony formation, as previously seen with p63−/− epidermal precursors
(Senoo et al., 2007), a phenotype that is likely at least partially due to increased senescence
and genomic instability, as we show here. Together, these findings indicate that TAp63
serves to regulate and maintain the adult stem cells that are essential to prevent premature
skin aging, and provide direct evidence that TAp63 has a physiologically important role in
regulating cellular senescence and genomic stability.
TAp63−/− mice exhibited signs of premature aging including hair loss, impaired wound
healing, kyphosis, and a median lifespan of only 48 weeks compared to 110 weeks for their
wild-type littermates. Intriguingly, premature aging has also been seen in mice mutant for
p53 (Tyner et al., 2002) and in p63+/− mice (Flores et al., 2005; Keyes et al., 2005).
Strikingly, the life span of TAp63 knockout mice is approximately half of that seen with
p63+/− mice (Flores et al., 2005; Keyes et al., 2005) suggesting that the p63+/− aging
phenotype is largely attributable to loss of TAp63. It is also tempting to speculate that p53
mouse models that display premature aging may do so via TAp63. Two mouse models
expressing truncated p53 mutants display premature aging (Maier et al., 2004; Tyner et al.,
2002), but other mouse models with elevated p53, the super p53 and mdm2puro/Δ7–12 mice
(Garcia-Cao et al., 2002; Mendrysa et al., 2006), do not. Perhaps these truncated p53
mutants bind to and inhibit TAp63, thereby causing premature aging. Precedent for such an
interaction comes from mouse models of Li-Fraumeni Syndrome (Iwakuma et al., 2005;
Lang et al., 2004) and from in vitro studies with point mutant p53 (Iwakuma et al., 2005).
How does TAp63 regulate aging? Our data indicate that it does so by regulating the
maintenance of adult tissue stem cells. In particular, we demonstrate that in the absence of
TAp63 in vivo, hair follicle dermal precursors display premature senescence, show signs of
DNA damage, and lose their ability to induce hair follicle morphogenesis. Moreover, since
follicle-associated precursors also contribute to dermal maintenance and wound-healing (J.
Biernaskie, L. Pevny, and F.D. Miller, unpublished observations), then deficits in this same
population may account for the wound healing and skin ulceration phenotypes seen in
TAp63−/− mice. In addition, epidermal precursors are highly deficient in colony formation
likely contributing to the skin phenotypes we document here. Moreover, we show that
TAp63 is essential to keep epidermal cells from senescing and to maintain their genomic
integrity. Thus, two adult skin precursor populations depend upon TAp63 for their
maintenance, and we propose that the loss of TAp63 leads to functional depletion of both
populations, resulting in premature skin aging. These findings provide significant support
for the concept that depletion of adult stem cells may be a major cause of tissue aging
(Sharpless and DePinho, 2007), and raise the possibility that functional depletion of adult
stem cells is responsible for the phenotypes of humans with dysregulated TAp63 (Gu et al.,
2006).
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At the cellular level, our data provide a number of TAp63-dependent mechanisms that
explain depletion of adult stem cell function. First, TAp63−/− SKPs showed increased
proliferation and self-renewal in culture, a phenotype that correlated with decreased
expression of p57Kip2, a direct transcriptional target of p63 (Beretta et al., 2005). Since adult
stem cell populations are not immortal, enhanced proliferation of follicle-associated SKPs
would be predicted to lead to stem cell depletion. Interestingly, re-expression of p57Kip2 in
TAp63−/− SKPs rescued the hyperproliferative phenotype of TAp63−/− SKPs indicating
that regulation of p57Kip2 by TAp63 is essential in the maintenance of these dermal
precursors. Second, in the absence of TAp63, both SKPs and epidermal cells displayed
greatly increased DNA damage and chromosomal aberrations indicating a key role for
TAp63 in regulating genomic stability and stem cell maintenance. Third, in the absence of
TAp63, both SKPs and epidermal cells displayed greatly increased senescence, something
that was also seen in vivo. TAp63 might directly regulate cellular senescence, as does p53,
or this senescence might occur in response to DNA damage or telomere shortening as a
consequence of hyperproliferation. The senescence induced by TAp63 is largely p53-
independent suggesting a unique senescence pathway regulated by TAp63. Regardless of the
trigger, senescence would withdraw stem cells from the cell cycle, thereby effectively
depleting them. All three mechanisms may be at play in the stem cell maintenance/
premature aging phenotypes that are observed in TAp63−/− mice.
The phenotype of the TAp63fl/fl;K14cre mice was strikingly different from that of the
TAp63−/− mice. The TAp63fl/fl;K14cre mice healed their wounds at similar rates to wild-
type mice and had similar numbers of BrdU positive cells in the dermal and epidermal
compartments. Additionally, epidermal cells derived from TAp63fl/fl;K14cre mice
proliferated similarly to wild-type epidermal cells. There are a number of possible
explanations for these data. First, the loss of TAp63 in epidermal cells may not be sufficient
for the deficits that are reported here; deletion of TAp63 in both dermal and epidermal
precursors might be required. Second, our results might be due to incomplete deletion of
TAp63 in the TAp63fl/fl;K14cre mice. However, our data demonstrating that TAp63 mRNA
is not detectable in primary embryonic epidermal cells by quantitative RT-PCR argues that
recombination has occurred in most epidermal cells by E18.5. Finally, these deficits may
require the loss of TAp63 in an embryonic epidermal precursor prior to the onset of K14cre
expression. Our data do not distinguish between these possibilities.
The p63 deficient mouse has craniofacial abnormalities and lacks stratified epithelium
resulting in death within hours after birth. Since this p63−/− mouse model lacks all isoforms
of p63, it has been difficult to specifically attribute these deficits to any particular
mechanism. One exception to this has been in the embryonic peripheral nervous system,
where neurons only express TAp63 isoforms, and where these isoforms act as essential
proapoptotic proteins during naturally-occurring cell death (Jacobs et al., 2005). The role of
the TAp63 isoforms has been less clear in the skin. The ΔN isoforms, most notably
ΔNp63α, are highly expressed in the basal layer of the epithelium, leading to the
assumption that they are responsible for the effects of p63 on proliferation of epidermal
precursors and development of the epidermis. Support for this idea comes from genetic
complementation experiments where TAp63α and ΔNp63α were expressed in K5-positive
cells in transgenic mice; expression of ΔNp63α showed a more impressive rescue of the
epidermis than did TAp63α (Candi et al., 2006). Our data are consistent with this
conclusion, since TAp63−/− mice do not display the same developmental skin phenotype as
p63−/− mice. Our data using mouse models indicate that TAp63 is important for skin
maintenance, primarily by acting in dermal and epidermal precursors. Importantly, the
TAp63−/− mice display a phenotype similar to defects in humans with Hay-Wells syndrome
where patients with mutations in p63 develop dermatitis and alopecia (McGrath et al.,
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2001). Thus, TAp63 and ΔNp63 might each play important roles in the skin via actions in
different compartments at different developmental time points.
In addition to its critical role in stem cell maintenance, TAp63 is induced in response to
stress. This is reminiscent of the induction of TAp63 in sympathetic neurons following
growth factor withdrawal (Jacobs et al., 2005) and of p53 after DNA damage. Since we also
observe a DNA damage response and chromosomal instability in TAp63−/− cells, then one
possibility is that TAp63 is induced with p53 as an essential part of a stress response to
protect the genome. Further support for this idea comes from previous reports that TAp63
plays a key role in maintaining the fidelity of the female germline (Suh et al., 2006), and that
p63 can act as a tumor suppressor gene (Flores, 2007; Flores et al., 2005). Thus, TAp63
likely acts with p53 and to maintain genomic integrity, thereby protecting long-lived cells
like stem cells, and potentially suppressing tumorigenesis. Interestingly, mouse models with
accumulated DNA damage, such as the ATRmKO mouse exhibit age-related phenotypes
(Ruzankina et al., 2007), supporting the idea that genomic instability in tissue stem cells is
one way that the loss of TAp63 causes premature aging.
In summary, the findings reported here indicate that TAp63 serves to maintain the adult
stem cells that are required for skin maintenance, thereby preventing premature aging.
TAp63 does this by regulating precursor cell proliferation, maintaining genomic integrity,
and preventing premature cellular senescence. Whether TAp63 or the related TAp73 play
similar roles in other adult stem cell populations, and whether TAp63 regulates genomic
integrity or cellular senescence in other normal or tumorigenic cells are key questions for the
future.
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Figure 1. TAp63−/− mice develop blisters and exhibit accelerated aging phenotypes
(A) Generation of the TAp63 conditional knockout mice. The TAp63 targeting vector was
generated by inserting loxP sites (triangles) flanking exon 2 and a neomycin (neo) cassette
flanked by frt sites (squares) in intron 2. Primers used for genotyping by PCR of wild-type
(blue) and TAp63 conditional knockout (fl) (red) alleles are shown. The targeted region of
the floxed allele is depicted by a dashed yellow line. (B) Southern blot analysis of genomic
DNA from TAp63fl/+, WT, and TAp63−/− mice. (C) PCR of DNA from wild-type (WT),
TAp63+/− (+/−) and TAp63−/− (−/−) mice. (D, E) Quantitative RT-PCR of (D) TAp63
mRNA from wild-type (WT) and TAp63−/− keratinocytes or of (E) ΔNp63 mRNA from
wild-type (blue) and TAp63−/− (red) keratinocytes and day 9.5 (E9.5) embryos. GAPDH
Su et al. Page 15













was used as an internal control. (F, G) Western blot for TAp63 (F) in wild-type (WT) and
TAp63−/− passage 2 keratinocytes or for ΔNp63 (G) in wild-type (WT) and TAp63−/− E9.5
and E13.5 embryos and keratinocytes. Actin was used as an internal control. (H) Dorsum of
an 8-month TAp63−/− mouse with an ulcerated wound. (I) H&E cross section of skin from a
1 month TAp63−/− mouse with a blister. Arrows indicate the split at the epidermal-dermal
junction with entrapped serum. (J, K) Immunocytochemistry for keratin 14 (green) and
collagen IV (red) of skin from 1 month wild-type (J) and TAp63−/− mice (K). DAPI was
used as a counterstain. Magnification 200X. White arrow indicates the beginning of the
dermal/epidermal separation. N=6 mice per group. (L) X-ray of 8 month wild-type (WT)
and TAp63−/− mice. (M) Kaplan-Meier survival curve for wild-type (WT) and TAp63−/−
mice. Median survival for TAp63−/− and WT mice is 333 and 712 days, respectively, n=29
mice per group, p<0.001.
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Figure 2. TAp63−/− mice lose hair follicles with age
(A) Confocal images of immunocytochemistry of a hair follicle from a young, wild-type
mouse for fibronectin (green), NCAM (dark blue), p63 (red), and Hoechst 33258 (blue).
Hatched line denotes the dermal papilla (DP), yellow arrowhead indicates a p63-positive
dermal sheath (DS) cell, arrows show a p63-positive dermal papilla cells, and white
arrowheads epidermal cells with nuclear p63. Magnification 630X. (B) RT-PCR for TAp63
mRNA in Sox2:EGFP-positive (+ve) and negative (−ve) cells from adult backskin. #1, 2 and
3 are samples from 3 different mice, and the ungated sample is total skin cells from one
mouse. (C) SA-β-gal staining (blue) of hair follicles in young wild-type or TAp63−/− skin
(left two panels). The arrows indicate SA-β-gal-positive dermal papillae. The right two
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panels, (a) and (b), are micrographs of sequential sections through the same hair follicle,
40µm apart. The arrowhead indicates an SA-β-gal-positive dermal sheath cell (DS), and the
arrows a positive dermal papilla (DP). (D) Quantification of SA-β-gal positive cells in the
dermal papillae (DP). n = 3 animals per group. *p<0.05. (E) H&E stained skin sections of 1,
6, and 12 month wild-type (WT) and TAp63−/− mice. Arrows denote hair follicles, and
double-arrows indicate regions of TAp63−/− skin depleted of hair follicles. Magnification
100X. (F) Quantification of hair follicles per millimeter (E). N = 8 and 4 mice each for wild-
type (WT) and TAp63−/− at 1 month and 12 months, respectively. *p<0.05. (G)
Quantification of hair follicles in wild-type (WT) and TAp63−/− mice at 1, 6–9, and 12
months. Only patches of skin with no follicles for greater than 400µm were included. N = 4
mice of each genotype at each time point. *p<0.05.
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Figure 3. TAp63−/− mice have an impaired wound-healing response
(A,B) Photomicrographs of wild-type (A) and TAp63−/− (B) H&E stained skin sections 6
days after wounding. Dotted lines indicate the dermal-epidermal boundary and boxes denote
area of immunohistochemical analysis on serial sections shown at higher magnification in
panels D, E, G, H, I, & J. (C) Bar graph indicating relative wound size 6 days after
wounding in wild-type (WT), TAp63−/− (−/−), TAp63fl/fl;K14cre− (K14cre−), and
TAp63fl/fl;K14cre+ (K14cre+) mice. N=6 mice per group, *p<0.05. (D,E)
Immunohistochemistry for BrdU incorporation 6 days after wounding in wild-type (D) and
TAp63−/− (E) mice. (F) Quantification of BrdU incorporation in epidermal cells in sections
shown in panels D,E in WT, TAp63−/−, TAp63fl/fl;K14cre−, and TAp63fl/fl;K14Cre+
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mice. N=6 mice per group, *p<0.001. (G–J) Immunohistochemistry for keratin 5 (G,H;
brown) or TAp63 (I,J; brown) in wild-type (G,I) or TAp63−/− (H,J) skin. (K) Quantification
of BrdU incorporation in dermal cells. In panels (D, E, G, H, I, J), tissue was counterstained
with hematoxylin. Arrowheads denote BrdU positive dermal and epidermal cells (D, E) and
TAp63-positive epidermal cells (I). N=6 mice per genotype. (L) qRT-PCR of mRNA from
WT, TAp63−/−, and TAp63fl/fl;K14cre+ epidermal cells extracted from E18.5 skin. N=6
mice per genotype in triplicate. (M) Western blots for TAp63 and p53 in stressed
keratinocytes (passage 2) and freshly-isolated keratinocytes (passage 0) from wild-type
(WT) and TAp63−/− mice. (N) Western blot for TAp63 in WT, TAp63−/−, and TAp63fl/
fl;K14cre+ stressed keratinocytes (passage 2). Actin was used as an internal control.
Keratinocytes derived from 3 independent embryos for each genotype and performed in
triplicate.
Su et al. Page 20













Figure 4. TAp63 regulates colony formation from epidermal precursors
(A) Epidermal colonies from wild-type (WT), TAp63fl/fl, TAp63−/−, TAp63−/−;p53−/−
and TAp63fl/fl;K14Cre+ mice cultured for 8 or 12 days on J2 3T3 feeder layers and stained
with rhodamine B. (B) Immunostaining for BrdU (green) and K5 (red) in wild-type and
TAp63−/− epidermal clones. (C,D) Quantification of BrdU incorporation in colonies after 8
(C) or 20 (D) days in culture. *p<0.05. N = 3 cell lines per genotype in triplicate. (E)
Immunostaining for the spinous marker, K10 (green), in wild-type (WT) and TAp63−/−
colonies cultured in high calcium (1.2 mM) media for 2 days. DAPI was used as a
counterstain.
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Figure 5. TAp63 regulates self-renewal of dermal precursors via p57Kip2
(A, B) RT-PCR in WT and p63−/− SKPs for (A) TAp63 and ΔNp63 mRNAs and (B) p53,
p73, and GAPDH mRNAs. Embryonic day 18 cortical tissue (C) was used as a positive
control. (C) Immunocytochemistry for p63 (green) in SKP spheres isolated from WT skin,
from reconstituted hair follicles (WT follicle), or from E18 p63−/− skin. Hoechst (blue) used
as a counterstain. Magnification 400X. (D) SKP spheres isolated from young WT or
TAp63−/− skin, or from E18 p63−/− skin and immunostained for fibronectin, nestin,
vimentin, smooth muscle actin (SMA) and versican. Magnification 400X. (E) SKP spheres
isolated from neonatal WT skin or from E18 p63−/− skin, immunostained for Ki67 (red),
and counterstained with Hoechst (blue). Magnification 400X. (F) Quantification of Ki67
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positive cells. n = 3, *p < 0.05. (G) Quantification of cells that form a new sphere at clonal
density (2500 cells/ml) in methylcellulose cultures. n = 3, *p < 0.05. (H) RT-PCR analysis
for p57Kip2 and GAPDH mRNAs in E18 cortex (C), young WT and TAp63−/− SKPs and
E18 p63−/− SKPs. (I) SKP spheres isolated from young WT and TAp63−/− skin,
immunostained for p57Kip2 (red) and counterstained for Hoechst (blue). Magnification
400X. (J) Quantification of p57Kip2 positive cells. n = 3, *p < 0.05. (K) ChIP for p63 in
young WT or E18 p63−/− SKPs and PCR for the p57Kip2 core promoter. (L)
Immunostaining for p57Kip2 (red) and Ki67 (green) in TAp63−/− SKPs transfected with or
without a p57Kip2 expression vector. Hoechst (blue) was used as a counterstain. Transfected
p57Kip2-positive cells were negative for Ki67. Magnification 200X, n=3.
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Figure 6. Loss of TAp63 causes dermal precursor cells to senesce
(A) SKP spheres from young WT and TAp63−/− SKPs stained for SA-β-gal (blue).
Magnification 400X. (B) SKP spheres from young and aged WT and young TAp63−/− skin
immunostained for p16Ink4a (red) and Ki67 (green) and counterstained with Hoechst (blue).
Green arrowheads indicate Ki67, white arrowheads indicate p16Ink4a, and white arrows
indicate Ki67 and p16Ink4a double positive cells. Magnification 400X. (C) Quantification of
p16Ink4a-positive and p16Ink4a, Ki67 double-positive cells. n = 3, *p < 0.05. (D) High
magnification of a TAp63−/− SKP cell nucleus that was labeled for p16Ink4a (red) and Ki67
(green) and counterstained with Hoechst (blue). (E,F) Quantification of SA-β-gal positive
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(E) or apoptotic (F) keratinocytes in wild-type (WT), TAp63−/−, and TAp63−/−;p53−/−
cultures. N=3 cell lines for each genotype, performed in triplicate. *p<0.0001.
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Figure 7. Loss of TAp63 leads to genomic instability
(A) SKP spheres from young and aged WT and TAp63−/− skin, immunostained for γ-
H2AX (green) and counterstained for Hoechst (blue). Magnification 400X. (B)
Quantification of γ-H2AX positive cells. n = 3, *p < 0.05. (C) Immunostaining for γ-H2AX
(green) in aged wild-type and young TAp63−/− skin and counterstained Hoechst (blue).
Arrows denote hair follicles, and arrowheads indicate positive cells within the dermal
sheath. Magnification 200X. (D) Immunostaining for γ-H2AX foci (red) in wild-type and
TAp63−/− keratinocytes. DAPI was used as a counterstain. (E) Metaphase spreads of wild-
type and TAp63−/− primary keratinocytes (passage 0). Cytogenetic aberrations in TAp63−/
− cells are indicated by colored arrows. Chromosomal fusions (black arrows), fragments
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(red arrows), breaks (green arrowheads), biarmed chromosomes (blue arrow), ring
chromosome (blue arrowhead).
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